Integrated care and optimal management of pulmonary arterial hypertension

References

• ShafazandSGoldsteinMKDoyleRLHlatkyMAGouldMKHealth-related quality of life in patients with pulmonary arterial hypertensionChest20041261452145915539712
   PubMed Web of Science ®Google Scholar
• D’AlonzoGEBarstRJAyresSMSurvival in patients with primary pulmonary hypertension. Results from a national prospective registryAnn Intern Med19911153433491863023
   PubMed Web of Science ®Google Scholar
• McLaughlinVVSitbonOBadeschDBSurvival with first-line bosentan in patients with primary pulmonary hypertensionEur Respir J20052524424915684287
   PubMed Web of Science ®Google Scholar
• WilliamsMHDasCHandlerCESystemic sclerosis associated pulmonary hypertension: improved survival in the current eraHeart20069292693216339813
   PubMed Web of Science ®Google Scholar
• RichSDantzkerDRAyresSMPrimary pulmonary hypertension. A national prospective studyAnn Intern Med19871072162233605900
   PubMed Web of Science ®Google Scholar
• SimonneauGGalieNRubinLJClinical classification of pulmonary hypertensionJ Am Coll Cardiol2004435S12S15194173
   PubMed Web of Science ®Google Scholar
• GalieNTorbickiABarstRGuidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of CardiologyEur Heart J2004252243227815589643
   PubMed Web of Science ®Google Scholar
• RubinLJDiagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelinesChest20041267S10S15249491
   PubMed Web of Science ®Google Scholar
• RunoJRLoydJEPrimary pulmonary hypertensionLancet20033611533154412737878
   PubMed Web of Science ®Google Scholar
• RichSExecutive summary from the world symposium on primary pulmonary hypertension Available at http://www.who.int/ncd/cvd/pph.htm.1998
   Google Scholar
• MaglianoMIsenbergDAHillsonJPulmonary hypertension in autoimmune rheumatic diseases: where are we now?Arthritis Rheum2002461997200912209501
   PubMed Web of Science ®Google Scholar
• FusterVSteelePMEdwardsWDGershBJMcGoonMDFryeRLPrimary pulmonary hypertension: natural history and the importance of thrombosisCirculation1984705805876148159
   PubMed Web of Science ®Google Scholar
• HoeperMMGalieNSimonneauGRubinLJNew treatments for pulmonary arterial hypertensionAm J Respir Crit Care Med20021651209121611991870
   PubMed Web of Science ®Google Scholar
• KimNHRubinLJEndothelin in health and disease: endothelin receptor antagonists in the management of pulmonary artery hypertensionJ Cardiovasc Pharmacol Ther2002791912000973
   PubMedGoogle Scholar
• RubinLJRouxSBosentan: a dual endothelin receptor antagonistExpert Opin Investig Drugs2002119911002
   PubMed Web of Science ®Google Scholar
• RouxSBreuVErtelSIClozelMEndothelin antagonism with bosentan: a review of potential applicationsJ Mol Med19997736437610353441
   PubMed Web of Science ®Google Scholar
• HumbertMMorrellNWArcherSLCellular and molecular pathobiology of pulmonary arterial hypertensionJ Am Coll Cardiol20044313S24S15194174
   PubMed Web of Science ®Google Scholar
• BarstRJPDGF signaling in pulmonary arterial hypertensionJ Clin Invest20051152691269416200204
   PubMed Web of Science ®Google Scholar
• McGoonMGuttermanDSteenVScreening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelinesChest200412614S34S15249493
   PubMed Web of Science ®Google Scholar
• ProudmanSMStevensWMSahharJCelermajerDPulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatmentIntern Med J20073748549417547726
   PubMed Web of Science ®Google Scholar
• HachullaECoghlanJGA new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonismAnn Rheum Dis2004631009101415308510
   PubMed Web of Science ®Google Scholar
• HumbertMSitbonOChaouatAPulmonary arterial hypertension in France: results from a national registryAm J Respir Crit Care Med20061731023103016456139
   PubMed Web of Science ®Google Scholar
• PeacockAJMurphyNFMcMurrayJJCaballeroLStewartSAn epidemiological study of pulmonary arterial hypertensionEur Respir J20073010410917360728
   PubMed Web of Science ®Google Scholar
• RubinLJPrimary pulmonary hypertensionN Engl J Med19973361111178988890
   PubMed Web of Science ®Google Scholar
• GaineSPRubinLJPrimary pulmonary hypertensionLancet19983527197259729004
   PubMed Web of Science ®Google Scholar
• GalieNManesAUguccioniLPrimary pulmonary hypertension: insights into pathogenesis from epidemiologyChest1998114184S194S9741567
   PubMed Web of Science ®Google Scholar
• BattleRWDavittMACooperSMPrevalence of pulmonary hypertension in limited and diffuse sclerodermaChest1996110151515198989070
   PubMed Web of Science ®Google Scholar
• KohETLeePGladmanDDAbu-ShakraMPulmonary hypertension in systemic sclerosis: an analysis of 17 patientsBr J Rheumatol1996359899938883438
   PubMedGoogle Scholar
• MacGregorAJCanavanRKnightCPulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survivalRheumatology (Oxford)20014045345911312386
   PubMed Web of Science ®Google Scholar
• PopeJELeePBaronMPrevalence of elevated pulmonary arterial pressures measured by echocardiography in a multicenter study of patients with systemic sclerosisJ Rheumatol2005321273127815996064
   PubMed Web of Science ®Google Scholar
• SchachnaLWigleyFMChangBWhiteBWiseRAGelberACAge and risk of pulmonary arterial hypertension in sclerodermaChest20031242098210414665486
   PubMed Web of Science ®Google Scholar
• GabbayEYeowWPlayfordDPulmonary arterial hypertension is an uncommon cause of pulmonary hypertension in an unselected population: The Armadale echocardiography studyProceedings of the American Thoracic Society Annual Meeting2007 May 18–23San Francisco, California
   Google Scholar
• Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and IrelandHeart200894Suppl 1i14118276826
   PubMed Web of Science ®Google Scholar
• NauserTDStitesSWDiagnosis and treatment of pulmonary hypertensionAm Fam Physician2001631789179811352291
   PubMed Web of Science ®Google Scholar
• BarstRJMcGoonMTorbickiADiagnosis and differential assessment of pulmonary arterial hypertensionJ Am Coll Cardiol20044340S47S15194177
   PubMed Web of Science ®Google Scholar
• BorgesonDDSewardJBMillerFAJrOhJKTajikAJFrequency of Doppler measurable pulmonary artery pressuresJ Am Soc Echocardiogr199698328378943443
   PubMedGoogle Scholar
• BarstRJPulmonary arterial hypertension: Evidence-based treatmentWiltshireWiley2008
   Google Scholar
• PhungSStrangeGChungLPPrevalence of pulmonary arterial hypertension in an Australian scleroderma population: Screening allows for earlier diagnosisIntern Med J2008
   Web of Science ®Google Scholar
• BadeschDBAbmanSHAhearnGSMedical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelinesChest200412635S62S15249494
   PubMed Web of Science ®Google Scholar
• DoyleRLMcCroryDChannickRNSimonneauGConteJSurgical treatments/interventions for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelinesChest200412663S71S15249495
   PubMed Web of Science ®Google Scholar
• McLaughlinVVPresbergKWDoyleRLPrognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelinesChest200412678S92S15249497
   PubMed Web of Science ®Google Scholar
• OgataMOheMShiratoKTakishimaTEffects of a combination therapy of anticoagulant and vasodilator on the long-term prognosis of primary pulmonary hypertensionJpn Circ J19935763698437343
   PubMedGoogle Scholar
• RichSKaufmannELevyPSThe effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertensionN Engl J Med199232776811603139
   PubMed Web of Science ®Google Scholar
• BarstRJRubinLJLongWAA comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study GroupN Engl J Med19963342963028532025
   PubMed Web of Science ®Google Scholar
• StewartSStrangeGA clinician’s guide to pulmonary arterial hypertensionSecond editionInforma Healthcare2008
   Google Scholar
• GalieNManesABranziAThe endothelin system in pulmonary arterial hypertensionCardiovasc Res20046122723714736539
   PubMed Web of Science ®Google Scholar
• StewartDJLevyRDCernacekPLanglebenDIncreased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?Ann Intern Med19911144644691994793
   PubMed Web of Science ®Google Scholar
• ChannickRNSimonneauGSitbonOEffects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled studyLancet20013581119112311597664
   PubMed Web of Science ®Google Scholar
• JaisXD’ArminiAMJansaPBosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trialJ Am Coll Cardiol2008522127213419095129
   PubMed Web of Science ®Google Scholar
• GatzoulisMABeghettiMGalieNLonger-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension studyInt J Cardiol2008127273217658633
   PubMed Web of Science ®Google Scholar
• GalieNRubinLHoeperMTreatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trialLancet20083712093210018572079
   PubMed Web of Science ®Google Scholar
• RubinLJBadeschDBBarstRJBosentan therapy for pulmonary arterial hypertensionN Engl J Med200234689690311907289
   PubMed Web of Science ®Google Scholar
• BarstRJIvyDDingemanseJPharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertensionClin Pharmacol Ther20037337238212709727
   PubMed Web of Science ®Google Scholar
• SitbonOGressinVSpeichRBosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertensionAm J Respir Crit Care Med20041701212121715317666
   PubMed Web of Science ®Google Scholar
• DentonCPPopeJEPeterHHLong-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseasesAnn Rheum Dis2008671222122818055477
   PubMed Web of Science ®Google Scholar
• GalieNHinderliterALTorbickiAEffects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertensionJ Am Coll Cardiol2003411380138612706935
   PubMed Web of Science ®Google Scholar
• HumbertMSegalESKielyDGCarlsenJSchwierinBHoeperMMResults of European post-marketing surveillance of bosentan in pulmonary hypertensionEur Respir J20073033834417504794
   PubMed Web of Science ®Google Scholar
• BarstRJLanglebenDBadeschDTreatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentanJ Am Coll Cardiol2006472049205616697324
   PubMed Web of Science ®Google Scholar
• BarstRJLanglebenDFrostASitaxsentan therapy for pulmonary arterial hypertensionAm J Respir Crit Care Med200416944144714630619
   PubMed Web of Science ®Google Scholar
• BenzaRLBarstRJGalieNSitaxsentan for the treatment of pulmonary arterial hypertension: a 1-year, prospective, open-label observation of outcome and survivalChest200813477578218625676
   PubMed Web of Science ®Google Scholar
• GalieNBadeschDOudizRAmbrisentan therapy for pulmonary arterial hypertensionJ Am Coll Cardiol20054652953516053970
   PubMed Web of Science ®Google Scholar
• BarstRJRubinLJMcGoonMDCaldwellEJLongWALevyPSSurvival in primary pulmonary hypertension with long-term continuous intravenous prostacyclinAnn Intern Med19941214094158053614
   PubMed Web of Science ®Google Scholar
• McLaughlinVVShillingtonARichSSurvival in primary pulmonary hypertension: the impact of epoprostenol therapyCirculation20021061477148212234951
   PubMed Web of Science ®Google Scholar
• SitbonOHumbertMNunesHLong-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survivalJ Am Coll Cardiol20024078078812204511
   PubMed Web of Science ®Google Scholar
• GalieNGhofraniHATorbickiASildenafil citrate therapy for pulmonary arterial hypertensionN Engl J Med20053532148215716291984
   PubMed Web of Science ®Google Scholar
• McLaughlinVVGaineSPBarstRJEfficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertensionJ Cardiovasc Pharmacol20034129329912548091
   PubMed Web of Science ®Google Scholar
• ProvencherSSitbonOSimonneauGTreatment of pulmonary arterial hypertension with bosentan: from pathophysiology to clinical evidenceExpert Opin Pharmacother200561337134816013984
   PubMed Web of Science ®Google Scholar
• HoeperMMMarkevychISpiekerkoetterEWelteTNiedermeyerJGoal-oriented treatment and combination therapy for pulmonary arterial hypertensionEur Respir J20052685886316264047
   PubMed Web of Science ®Google Scholar
• OpitzCFWenselRWinklerJClinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertensionEur Heart J2005261895190215888496
   PubMed Web of Science ®Google Scholar
• SimonneauGRubinLJGalieNAddition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trialAnn Intern Med200814952153018936500
   PubMed Web of Science ®Google Scholar
• Recommendations on the management of pulmonary hypertension in clinical practiceHeart200186Suppl 1I11311473937
   PubMed Web of Science ®Google Scholar
• SandovalJRothmanAPulidoTAtrial septostomy for pulmonary hypertensionClin Chest Med20012254756011590848
   PubMed Web of Science ®Google Scholar
• TaichmanDBShinJHudLHealth-related quality of life in patients with pulmonary arterial hypertensionRespir Res200569216092961
   PubMed Web of Science ®Google Scholar
• ArchibaldCJAugerWRFedulloPFLong-term outcome after pulmonary thromboendarterectomyAm J Respir Crit Care Med199916052352810430723
   PubMed Web of Science ®Google Scholar
• MikhailGWPrasadSKLiWClinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effectsEur Heart J20042543143615033256
   PubMed Web of Science ®Google Scholar
• OlschewskiHSimonneauGGalieNInhaled iloprost for severe pulmonary hypertensionN Engl J Med200234732232912151469
   PubMed Web of Science ®Google Scholar
• SastryBKNarasimhanCReddyNKRajuBSClinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover studyJ Am Coll Cardiol2004431149115315063421
   PubMed Web of Science ®Google Scholar
• SimonneauGBarstRJGalieNContinuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trialAm J Respir Crit Care Med200216580080411897647
   PubMed Web of Science ®Google Scholar
• SouzaRJardimCMartinsBEffect of bosentan treatment on surrogate markers in pulmonary arterial hypertensionCurr Med Res Opin20052190791115969891
   PubMed Web of Science ®Google Scholar
• StrangeGGabbayEWilliamsTWlodarczykJMcNeilKKeoghABosentan therapy in patients with pulmonary arterial hypertension: the relationship between improvements in six-minute walk test and quality of lifeRespirology20081367468218713089
   PubMed Web of Science ®Google Scholar
• MerelesDEhlkenNKreuscherSExercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertensionCirculation20061141482148916982941
   PubMed Web of Science ®Google Scholar
• McDonaldKLedwidgeMCahillJHeart failure management: multidisciplinary care has intrinsic benefit above the optimization of medical careJ Card Fail2002814214812140806
   PubMed Web of Science ®Google Scholar
• Organised inpatient (stroke unit) care for strokeStroke Unit Trialists’ CollaborationCochrane Database Syst Rev2000CD00019710796318
   PubMedGoogle Scholar
• HankeyGJWarlowCPTreatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populationsLancet19993541457146310543686
   PubMed Web of Science ®Google Scholar
• AugustDACarpenterLCHarnessJKBenefits of a multidisciplinary approach to breast careJ Surg Oncol1993531611678331938
   PubMed Web of Science ®Google Scholar